The addiction treatment industry is unlikely to return to the era of high multiples and competitive private equity bidding that defined the post-pandemic market. But that is not necessarily a negative. In 2026, the industry has a more grounded approach to deals. Investors are looking for companies with sustainable growth, strong clinical programs and solid compliance infrastructure. Several companies in the SUD sector have struggled over the past few years. For example, Patient Square Capital-backed Summit BHC recently had its credit outlook revised from positive to negative following an out-of-court debt restructuring. Additionally, BayMark Health’s creditors reportedly took control of the company during a debt restructuring.
Read the full article: Tale of Two Cities: SUD Dealmaking Market Divided into Haves and Have Nots //
Source: https://bhbusiness.com/2026/07/20/tale-of-two-cities-sud-dealmaking-market-divided-into-haves-and-have-nots/